Result Update:TCS
Axis Direct
We recommend a BUY rating on the stock.
Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
---|---|---|---|---|---|---|---|---|---|---|---|
10 Oct 2025 | TCS |
Axis Direct
|
2970.70 | 3460.00 | 3028.30 (-1.90%) | 16.47 |
Buy
|
||||
10 Oct 2025 | World Economy and Markets |
Axis Direct
|
Daily Note
|
||||||||
10 Oct 2025 | Market Movement |
Axis Direct
|
Top Picks
|
||||||||
10 Oct 2025 | Market Movement |
Axis Direct
|
Strategy Note
|
||||||||
10 Oct 2025 | Ambuja Cements |
Ventura
|
569.70 | 794.00 | 569.25 (0.08%) | 39.37 |
Buy
|
||||
10 Oct 2025 | Market Movement |
Ventura
|
Daily Note
|
||||||||
10 Oct 2025 | TCS |
ICICI Direct
|
2970.70 | 3640.00 | 3028.30 (-1.90%) | 22.53 |
Buy
|
Tata Consultancy Services
ICICI Direct
Strengthened Salesforce capabilities through ListEngage acquisition: TCS announced acquisition of US-based ListEngage for up to US$ 72.8 million (~640 crore), in order to enhance its Salesforce, Agentic AI, and marketing automation capabilities, along with addition of 100+ specialists. Combined with its expanding AI, cloud, and data modernization portfolio, these investments strengthen TCS's positioning for a gradual growth recovery...
|
|||
10 Oct 2025 | Chemicals & Petrochemicals |
BP Wealth
|
Sector Update
|
||||||||
10 Oct 2025 | TCS |
Deven Choksey
|
2970.70 | 3615.00 | 3061.70 (-2.97%) | 21.69 |
Buy
|
A resilient quarter marked by margin expansion, strong deal momentum, and stable execution amid macro headwinds
Deven Choksey
Headcount optimization, stable attrition, and wage normalization supported margins in Q2. Combined with strong deal momentum and AI-led transformation investments, these factors are expected to drive margin resilience and revenue acceleration in H2FY26.
|
|||
10 Oct 2025 | Tata Elxsi |
Deven Choksey
|
5403.50 | 4884.00 | 5573.00 (-3.04%) | 9.61 |
Sell
|
Near-term challenges persist despite long-term strengths; growth recovery likely gradual
Deven Choksey
We have revised our FY26E/FY27E EPS estimates by 0.4%/-0.8% as we maintain a cautious near-term outlook, given the temporary impact of the cybersecurity incident, moderation in media and communications growth, and slower recovery in healthcare.
|
|||
more
loading
|